China Expects Major Changes in Drug Registration and Contract Manufacturing Rules
By EsqSocial Corporation 18/11/13
The China Food and Drug Administration (“CFDA”) recently announced several draft rules, most notably, the Draft Amendment of the Provisions for Drug Registration (also known as the Drug Registration Rules, DRR) and the Draft Administrative...
By: Ropes & Gray LLP